RAMIK, Zdenek, Jan VACLAVIK, Tomas KVAPIL, Libor JELINEK, Eva KOCIANOVA, Monika KAMASOVA, Klára BENEŠOVÁ, Jiří JARKOVSKÝ, Martin DRAPELA and Zdenek LYS. Long-term trajectory of renal dysfunction and related risk factors in patients with apparently treatment-resistant and non-resistant arterial hypertension. Blood Pressure. OXON: TAYLOR & FRANCIS LTD, 2024, vol. 33, No 1, p. 1-11. ISSN 0803-7051. Available from: https://dx.doi.org/10.1080/08037051.2024.2353836.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Long-term trajectory of renal dysfunction and related risk factors in patients with apparently treatment-resistant and non-resistant arterial hypertension
Authors RAMIK, Zdenek (203 Czech Republic), Jan VACLAVIK (203 Czech Republic), Tomas KVAPIL (203 Czech Republic), Libor JELINEK (203 Czech Republic), Eva KOCIANOVA (203 Czech Republic), Monika KAMASOVA (203 Czech Republic), Klára BENEŠOVÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Martin DRAPELA (203 Czech Republic) and Zdenek LYS (203 Czech Republic).
Edition Blood Pressure, OXON, TAYLOR & FRANCIS LTD, 2024, 0803-7051.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.800 in 2022
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1080/08037051.2024.2353836
UT WoS 001242078200001
Keywords in English Arterial hypertension; resistant arterial hypertension; chronic kidney disease; estimated glomerular filtration rate; spironolactone; eplerenone
Tags 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 25/6/2024 14:38.
Abstract
Objectives: Evidence suggests that renal function increasingly deteriorates in patients with apparently treatment-resistant hypertension (AT RH) in comparison with those who have non-resistant arterial hypertension (NAH). We aimed to assess the long-term decline in renal function between these patient groups and identify specific risk factors contributing to the progression of renal dysfunction.
PrintDisplayed: 10/7/2024 20:48